CAS No. 1206799-15-6
Batch:
Purity:99.78
Chemical Structure
Check the
Merestinib (LY2801653)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide | |
|---|---|---|
| CAS Number | 1206799-15-6 | |
| Molecular Formula |
C30H22F2N6O3 |
|
| Molecular Weight (MW) | 552.53 | |
| SMILES | CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F | |
| InChIKey | QHADVLVFMKEIIP-UHFFFAOYSA-N |
Merestinib (LY2801653) is a type-II ATP-competitive inhibitor targeting MET (Ki 2 nM), AXL (IC50 2 nM), FLT3, MERTK, MST1R, and DDR1. By suppressing receptor tyrosine kinase auto-phosphorylation, it impairs downstream MET and AXL signal transduction, inhibiting tumor cell proliferation, migration, and survival across multiple oncogenic models. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(180.98 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 100 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- Merestinib (LY2801653) Clinical Trials
- Merestinib (LY2801653) Solubility in DMSO
- Merestinib (LY2801653) Stock Solution
- Merestinib (LY2801653) Storage
- Merestinib (LY2801653) Stability
- Merestinib (LY2801653) Molecular Weight
- Merestinib (LY2801653) SMILES
- Merestinib (LY2801653) Chemical Structure (2D and 3D)
- Merestinib (LY2801653) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.